List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 23 studies with search of: "Pozen" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting A 12-Month, Phase 3, Open-Label, Multi-Center Study to Evaluate the Long-Term Safety of PN 400
Condition: Gastric Ulcer
Intervention: Drug: PN400
2 Completed PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400
Condition: Healthy
Intervention: Drug: PN400
3 Completed An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers
Condition: Healthy
Intervention: Drug: PN 200
4 Completed Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.
Conditions: Osteoarthritis;   Rheumatoid Arthritis;   Ankylosing Spondylitis
Interventions: Drug: PN 200 tablets (500 mg naproxen and 20 mg omeprazole);   Drug: Naproxen 500 mg tablets (PN 200 minus omeprazole)
5 Completed A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin
Condition: Healthy
Interventions: Drug: aspirin;   Drug: omeprazole
6 Completed The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
Condition: Migraine Headaches
Intervention: Drug: Sumatriptan and Naproxen sodium
7 Completed Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy
Conditions: Bunionectomy;   Orthopedic Surgery
Interventions: Drug: Lornoxicam 8 mg;   Drug: Lornoxicam 16 mg;   Drug: Ketorolac 30 mg;   Drug: Placebo
8 Completed Study Evaluating the Efficacy of PN 400 BID and Celecoxib QD in Patients With Osteoarthritis of the Knee
Condition: Osteoarthritis
Interventions: Drug: PN 400;   Drug: celebrex;   Drug: Placebo
9 Completed To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
Condition: Migraine Headaches
Interventions: Drug: sumatriptan;   Drug: naproxen sodium
10 Completed Study Evaluating the Effect of Food on the Bioavailability of PN400 Components
Condition: Arthritis
Intervention: Drug: PN400
11 Completed Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations
Condition: Arthritis
Interventions: Drug: PN400;   Drug: naproxen;   Drug: naproxen
12 Completed Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets
Condition: Healthy
Intervention: Drug: MT400
13 Completed To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin
Condition: Healthy
Interventions: Drug: aspirin;   Drug: omeprazole
14 Terminated Study to Evaluate the Incidence of Gastric Ulcers With PN 400 (Esomeprazole/Naproxen) Versus Diclofenac/Misoprostol in Subjects Who Are at High Risk for Developing NSAID-Associated Ulcers
Condition: Gastric Ulcer
Interventions: Drug: Diclofenac/misoprostol;   Drug: PN400
15 Completed Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
Condition: Arthritis
Interventions: Drug: PN400;   Drug: Naproxen
16 Completed Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.
Condition: Headache (Migraine)
Interventions: Drug: Lornoxicam 8 mg;   Drug: Lornoxicam 16 mg;   Drug: Placebo
17 Completed Study Evaluating the Efficacy of PN 400 BID and Celebrex QD in Patients With Osteoarthritis of the Knee
Condition: Osteoarthritis
Interventions: Drug: PN 400;   Drug: celebrex;   Drug: Placebo
18 Completed To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
Condition: Migraine Headaches
Interventions: Drug: sumatriptan;   Drug: naproxen sodium
19 Completed A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
Condition: Arthritis
Interventions: Drug: PN 400;   Drug: EC naproxen plus EC esomeprazole;   Drug: EC naproxen;   Drug: EC esomeprazole
20 Completed Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers
Condition: Healthy
Interventions: Drug: PA32540;   Drug: aspirin component of PA32540;   Drug: Ecotrin

Previous Page Studies Shown (1-20) Next Page (21-23)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services